Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202) - Rubenstein, J L; Hsi, E D; Johnson, J L (J Clin Oncol, 2013)
, et al.